StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research report sent to investors on Monday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Stock Performance
CPIX opened at $1.24 on Monday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.44 and a quick ratio of 1.26. The firm has a fifty day moving average price of $1.38 and a 200 day moving average price of $1.52. Cumberland Pharmaceuticals has a 1 year low of $1.22 and a 1 year high of $2.36. The stock has a market cap of $17.60 million, a P/E ratio of -2.10 and a beta of 0.20.
Cumberland Pharmaceuticals Company Profile
See Also
- Five stocks we like better than Cumberland Pharmaceuticals
- Dividend Capture Strategy: What You Need to Know
- The Average 401k Balance by Age Explained
- 3 REITs to Buy and Hold for the Long Term
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- 5 discounted opportunities for dividend growth investors
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.